Cite

HARVARD Citation

    Ray, K. et al. (2020). Effect of inclisiran on atherogenic lipoproteins in high-risk primary prevention populations: analysis from the phase III ORION-11 trial. Atherosclerosis. pp. e8-. [Online]. 
  
Back to record